GGrantIndex
Sort

261,768 grants matching gene therapy

Strategies for Cancer Immunotherapy Development: Preclinical Studies

$1,535,915
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Activities Of Chemokines In Health and Disease

$1,535,657
Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease

$1,535,619
Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease

$1,535,611
Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2024 · AI

Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease

$1,535,611
Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2022 · AI

Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease

$1,535,611
Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2025 · AI

Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease

$1,535,611
Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2023 · AI

Targeted Therapy in Neuroendocrine Cancer

$1,535,487
Samira Sadowski · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Lambda Genetic Networks and Lambda Red-Mediated Recombination

$1,535,431
Donald Court · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Gene Therapy for Vaso-occlusive Disorders

$1,535,197
Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2002 · HL

Human pluripotent stem cells

$1,535,167
Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2024 · NS

Pathophysiologic and Therapeutic Mechanisms of Aspirin Exacerbated Respiratory Disease

$1,535,096
Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2021 · AI

Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma

$1,534,851
Anuradha Ray · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · AI

A comprehensive platform for novel therapy development from the microbiome

$1,534,850
Curtis Huttenhower · Broad Institute, Inc. · R24 · FY2018 · DK

Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma

$1,534,850
Anuradha Ray · University Of Pittsburgh At Pittsburgh · P01 · FY2016 · AI

Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis

$1,534,755
Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · AR

HSC DIFFERENTIATION

$1,534,582
Children'S Hospital Los Angeles · P50 · FY2003 · HL

Investigations of Methylmalonic Acidemia and Related Disorders

$1,534,433
Charles P Venditti · National Human Genome Research Institute · ZIA · FY2019 · HG

Rare Disease Network for Myasthenia Gravis

$1,534,359
Henry J Kaminski · George Washington University · U54 · FY2023 · NS

Gene Targets for Intraventricular Hemorrhage (IVH)

$1,534,343
Laura R. Ment · Yale University · R01 · FY2010 · NS

CTL and HIV Polymorphisms in Heterosexual Transmission

$1,534,304
Eric Hunter · Emory University · R01 · FY2015 · AI

DNA Vaccines

$1,533,961
George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma

$1,533,612
Anuradha Ray · University Of Pittsburgh At Pittsburgh · P01 · FY2018 · AI

Primary Immune Deficiency Treatment Consortium

$1,533,468
Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2018 · AI

Genome Characterization Unit

$1,533,382
Jeffrey M. Trent · University Of New Mexico Health Scis Ctr · U2C · FY2025 · CA